IPO registrations (S-1, F-1) · Registrants
GENOMIC HEALTH INC
- SEC CIK
- 1131324 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2005-07-15, last 2005-09-28; 1 initial registration, 6 amendments
- Outcome
- Final prospectus filed 2005-09-29; declared effective 2007-04-26
- Industry (SIC)
- Services-Medical Laboratories 8071
- Business address
- 301 PENOBSCOT DRIVE, Redwood City, CA 94063
- EIN
- 77-0552594
- EDGAR entity type
- operating
- Insiders and CEO pay
- GENOMIC HEALTH INC on the corporate pages
Offering terms
- Proposed price range
- $12.00–$14.00 per share (S-1/A filed 2005-09-28)
- Final price
- $12.00 per share, within the range (424B4 filed 2005-09-29, an initial public offering)
- Shares sold
- 5,016,722
- Gross proceeds
- $60,200,664 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol GHDX
- Lead underwriters
- J.P. Morgan; Lehman Brothers; Piper Sandler; Thomas Weisel Partners; JMP Securities
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: GENOMIC HEALTH, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: GENOMIC HEALTH, INC. EXACT (EIN (EXACT))
- Federal award recipient: GENOMIC HEALTH, INC. Fuzzy (name and state)
- Lobbying client: GENOMIC HEALTH Fuzzy (name and state)
- Lobbying client: GENOMIC HEALTH INC Fuzzy (name and state)
- Lobbying client: GENOMIC HEALTH INC Fuzzy (name and state)
- Lobbying client: GENOMIC HEALTH INC. Fuzzy (name and state)
- Lobbying registrant: GENOMIC HEALTH Fuzzy (name and state)
- SEC filer: GENOMIC HEALTH INC EXACT (CIK (EXACT))
- Person page: Brook H Byers Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 9
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2005-07-15 | S-1 | S-1 (registration) | GENOMIC HEALTH INC | 0000891618-05-000492 ↗ |
| 2005-08-22 | S-1/A | S-1/A (amendment) | GENOMIC HEALTH INC | 0000891618-05-000632 ↗ |
| 2005-09-09 | S-1/A | S-1/A (amendment) | GENOMIC HEALTH INC | 0000950134-05-017441 ↗ |
| 2005-09-13 | S-1/A | S-1/A (amendment) | GENOMIC HEALTH INC | 0000891618-05-000704 ↗ |
| 2005-09-20 | S-1/A | S-1/A (amendment) | GENOMIC HEALTH INC | 0000950134-05-017962 ↗ |
| 2005-09-26 | S-1/A | S-1/A (amendment) | GENOMIC HEALTH INC | 0000891618-05-000748 ↗ |
| 2005-09-28 | S-1/A | S-1/A (amendment) | GENOMIC HEALTH INC | 0000950134-05-018498 ↗ |
| 2005-09-29 | 424B4 | 424B4 (final prospectus) | GENOMIC HEALTH INC | 0000950134-05-018526 ↗ |
| 2007-04-26 | EFFECT | EFFECT (declared effective) | GENOMIC HEALTH INC | 9999999995-07-001497 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2005-09-28 | S-1/A | registration statement | $12.00–$14.00 | $12.00 | 5,016,722 | $60,200,664 | Nasdaq GHDX | 5 | primary document; range, price table, shares headline, proceeds computed, cover names 5 | document ↗ |
| 2005-09-29 | 424B4 | final prospectus | $12.00 | 5,016,722 | $60,200,664 | Nasdaq GHDX | 5 | primary document; price sentence, shares headline, proceeds table, cover names 5 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| MYERS WOODROW A JR | Director | 26 | 2006–2013 | ||
| BAKER JULIAN | Director; Director,TenPercentOwner | 229 | 2006–2019 | ||
| 14159 capital (GP), LLC | Director; Director,TenPercentOwner | 41 | 2006–2012 | ||
| Baker Biotech Capital (GP), LLC | Director; Director,TenPercentOwner | 24 | 2006–2012 | ||
| Baker Brothers Life Sciences Capital (GP), LLC | Director; Director,TenPercentOwner | 42 | 2006–2012 | ||
| BAKER FELIX | Director; Director,TenPercentOwner; Other | 203 | 2006–2019 | ||
| BYERS BROOK H | Director | 7 | 2006–2011 | person page Fuzzy | |
| Cohen Fred E | Director | 62 | 2006–2019 | ||
| COLELLA SAMUEL D | Director | 30 | 2006–2014 | ||
| Goldberg Michael D | Director | 3 | 2006–2007 | ||
| LIVINGSTON RANDALL S | Director | 27 | 2006–2016 | ||
| Baker Joffre | Officer | Chief Scientific Officer | 53 | 2006–2012 | |
| Cole G Bradley | Officer | CFO; COO; COO & CFO; EVP and CFO; EVP & CFO | 133 | 2006–2019 | |
| Popovits Kimberly J | Director,Officer; Officer | President and CEO; President and COO; President & COO | 115 | 2006–2019 | |
| Scott Randal W | Director,Officer | CEO, InVitae Corporation; CEO, InVitae Corporation*; Chairman and CEO; Chief Executive Officer; Executive Chairman | 78 | 2006–2012 | |
| Shak Steven | Officer | Chief Medical Officer; Chief Scientific Officer; EVP of R&D; EVP of R&D & CMO | 103 | 2006–2019 | |
| Baker / Tisch Capital (GP), LLC | Director; Director,TenPercentOwner | 8 | 2006–2009 | ||
| Baker Bros. Capital (GP), LLC | Director; Director,TenPercentOwner | 16 | 2007–2011 | ||
| GRAHAM GINGER L | Director | 53 | 2008–2019 | ||
| Schorno Dean L | Officer | CFO | 36 | 2011–2014 | |
| BAKER BROS ADVISORS LLC | Director,TenPercentOwner | 91 | 2012–2019 | ||
| 14159, L.P. | Director; Director,TenPercentOwner | 88 | 2012–2019 | ||
| 667, L.P. | Director; Director,TenPercentOwner | 88 | 2012–2019 | ||
| Baker Bros. Investments II, L.P. | Director; Director,TenPercentOwner | 75 | 2012–2019 | ||
| Baker Bros. Investments, L.P. | Director; Director,TenPercentOwner | 76 | 2012–2019 | ||
| Baker Brothers Life Sciences LP | Director; Director,TenPercentOwner | 88 | 2012–2019 | ||
| Baker/Tisch Investments, LP | Director; Director,TenPercentOwner | 76 | 2012–2019 | ||
| FBB Associates | Director | 1 | 2012 | ||
| HIBBS KATHY L | Officer | SVP & General Counsel | 11 | 2012–2014 | |
| Baker Bros. Advisors (GP) LLC | Director,TenPercentOwner | 73 | 2013–2019 | ||
| FUCHS HENRY J | Director | 33 | 2013–2019 | ||
| Febbo Phillip G. | Officer | Chief Medical Officer | 11 | 2015–2018 | |
| Leber Laura | Officer | Chief Communication Officer | 17 | 2015–2019 | |
| McEachron Kim | Officer | Chief People Officer | 11 | 2015–2019 | |
| Pla Frederic | Officer | Chief Bus & Prod Dev Officer; COO | 18 | 2015–2019 | |
| Radford Jason W. | Officer | Chief Legal Officer | 17 | 2015–2019 | |
| Vaughn James J | Officer | Chief Commercial Officer | 37 | 2015–2019 | |
| Parker Geoffrey M. | Director | 6 | 2016–2019 | ||
| Flannelly Barry P | Director | 5 | 2019 | ||
| Hoof Torsten | Officer | Chief Int'l Commercial Officer | 2 | 2019 | |
| EXACT SCIENCES CORP | TenPercentOwnerOther | 2 | 2019 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | GENOMIC HEALTH, INC. | CA | State business registries | EIN (EXACT, as the state registration reports it) |
| Federal award recipient | GENOMIC HEALTH, INC. | CA | Federal spending (USAspending) | name and state |
| IPO registrant | ANERGEN INC | CA | IPO registrations (S-1, F-1) | same street address and ZIP code, 301 PENOBSCOT DR 94063 (FUZZY: a shared address, not proof of a shared organization) |
| Lobbying client | GENOMIC HEALTH | CA | Federal lobbying (LDA) | name and state |
| Lobbying client | GENOMIC HEALTH INC | CA | Federal lobbying (LDA) | name and state |
| Lobbying client | GENOMIC HEALTH INC | CA | Federal lobbying (LDA) | name and state |
| Lobbying client | GENOMIC HEALTH INC. | CA | Federal lobbying (LDA) | name and state |
| Lobbying registrant | GENOMIC HEALTH | CA | Federal lobbying (LDA) | name and state |
| Patent assignee | Genomic Health, Inc. | CA | Patents (USPTO) | name and state |
| SEC filer | GENOMIC HEALTH INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Genomic Health, Inc. | CA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | GENOMIC HEALTH, INC. | EIN (EXACT) | ||
| Person page | Brook H Byers | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Medical Laboratories, CA first:
- INSIGHT HEALTH SERVICES CORP CA
- CLARIENT, INC CA
- BIOCEPT INC CA
- SPECIALTY LABORATORIES INC CA
- PERLEGEN SCIENCES, INC. CA
- GENOPTIX INC CA
- INSIGHT HEALTH SERVICES HOLDINGS CORP CA
- CareDx, Inc. CA
- EXAGEN INC. CA
- CARDIODX INC CA
In other datasets, the same topic (Health) in CA:
- Nonprofit: 24 HOUR CANCER DANCE-A-THON (Nonprofits (IRS Form 990))
Interests: Services-Medical Laboratories · Health